Badgley Phelps Wealth Managers, LLC Gilead Sciences, Inc. Transaction History
Badgley Phelps Wealth Managers, LLC
- $4.25 Billion
- Q3 2024
A detailed history of Badgley Phelps Wealth Managers, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Badgley Phelps Wealth Managers, LLC holds 123,628 shares of GILD stock, worth $11.5 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
123,628
Previous 123,724
0.08%
Holding current value
$11.5 Million
Previous $8.49 Million
22.08%
% of portfolio
0.24%
Previous 0.21%
Shares
12 transactions
Others Institutions Holding GILD
# of Institutions
1,926Shares Held
993MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$11.2 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.7 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$7.1 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.74 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.58 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $116B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...